Botswana Medicines Regulatory Authority

Botswana Medicines Regulatory Authority Botswana Medicines Regulatory Authority (BoMRA) regulates the supply chain of Human & Veterinary med

NOTICE TO STAKEHOLDERSTemporary Closure of Licensing and Enforcement Office  Dear Valued Stakeholders,Please be advised ...
06/08/2026

NOTICE TO STAKEHOLDERS

Temporary Closure of Licensing and Enforcement Office

Dear Valued Stakeholders,

Please be advised that the Licensing and Enforcement Office will be closed on Thursday, 6 August 2026, due to scheduled maintenance by the Botswana Power Corporation (BPC), which will affect our office. During this period, stakeholders are encouraged to direct all enquiries through the following channels:

Email:
[email protected]
[email protected]
[email protected]
Telephone:
• +267 7584 6026
• +267 7700 5077

We sincerely apologise for any inconvenience this temporary disruption may cause and appreciate your patience and understanding as we work to restore normal services.

03/08/2026

Join the BoMRA PR Manager (Mr Israel Kgosidiile) and the Director, Product Evaluation and Registration (Mr Bathusi Kgosietsile) live on Duma FM today at 2000hrs (Vitals with Kealeboga Dihutso) for a discussion on Authorization of Medicines for Use in Botswana.

The interview shall also highlight valuable information on BoMRA’s regulatory role in ensuring that medicines authorized for use in Botswana meet the required standards of quality, safety, and efficacy.

VIRTUAL STAKEHOLDER ENGAGEMENT - VETERINARY MEDICINAL PRODUCTS (VMPs) The Department of Product Evaluation and Registrat...
31/07/2026

VIRTUAL STAKEHOLDER ENGAGEMENT - VETERINARY MEDICINAL PRODUCTS (VMPs)

The Department of Product Evaluation and Registration at BoMRA will conduct a virtual stakeholder engagement to discuss the new Regulatory fees, the revised Medicines and Related Substance Act of 2025 and submission of Veterinary Medicines Dossiers for Expedited Registration.

The stakeholder engagement targets all relevant VMP stakeholders inclusive of the principals, veterinary practitioners, manufacturers, applicants or potential Marketing Authorization Holders (MAHs) of VMPs, distributors / wholesalers, retailers, local representatives, associations, and facilities. The sessions will be scheduled as follows:

Date: 27th August 2026 TIME: 0900 - 1200hrs

Please use the link provided below to register your intention to attend the stakeholder engagement session, before or by the 25th of August 2026. Detailed information regarding the stakeholder engagement will be communicated directly to the confirmed attendees.

Link: https://forms.gle/WKrgy1JnPCf6rZwF9
If there are any further questions on this notice or any other issue related to this communication, please kindly contact the Botswana Medicines Regulatory Authority at: +267 3731760, +267 74985066 or +267 75846037 [email protected]

Wishing all Batswana a safe, joyful, and memorable President's Holiday.
21/07/2026

Wishing all Batswana a safe, joyful, and memorable President's Holiday.

Happy President’s Holidays.
20/07/2026

Happy President’s Holidays.

President's Day Office Closure Notice
17/07/2026

President's Day Office Closure Notice

BoMRA Vacancies VACANCY: DOSSIER ASSESSOR (X2)JOB PURPOSEThe Dossier Assessor is responsible for evaluating applications...
16/07/2026

BoMRA Vacancies
VACANCY: DOSSIER ASSESSOR (X2)
JOB PURPOSE
The Dossier Assessor is responsible for evaluating applications for the registration and authorization of human medicines, veterinary medicines, complementary medicines, and regulated cosmetic products, ensuring that products placed on the Botswana market comply with applicable legal and regulatory requirements relating to quality, safety, efficacy (where applicable), and cosmetic safety and compliance
KEY RESPONSIBILITIES
• Assist in the evaluation of dossiers for human, veterinary, complementary medicines, and cosmetic products to ensure compliance with applicable regulatory requirements
• Develop, review, and implement processes, standards, guidelines, and technical requirements for the registration, listing, and authorization of medicines and cosmetic products.
• Conduct administrative and technical assessments of applications for pre-market authorization, post-registration variations, renewals, and cosmetic notifications/listings where applicable.
• Prepare detailed technical assessment reports on the acceptability of data submitted in registration applications.
• Work closely with the Manager and Head of the Evaluation and Registration Department to ensure that approved and authorized products on the market continue to meet regulatory requirements.
• Prepare and review technical documents, reports, and committee submissions for regulatory decision-making.
• Process applications for exemptions from registration of regulated products.
• Ensure timely communication of assessment outcomes and regulatory decisions to applicants.
• Maintain up-to-date medicine registers and regulatory databases.
• Assist in updating and maintaining Standard Operating procedures (SOPs), templates, and regulatory guidance documents.
• Engage, educate, and provide regulatory guidance on medicines and cosmetic product requirements.
• Contribute to continuous improvement initiatives by monitoring international regulatory developments and recommending enhancements to regulatory practices.

QUALIFICATIONS & EXPERIENCE
• Bachelor's degree in pharmacy, Medicine, Pharmacology, Toxicology, Pharmaceutical Sciences, or a related field from a recognized institution. Applicants from non-pharmacy disciplines should demonstrate relevant experience or training in medicines
• At least three (3) years' relevant experience in the pharmaceutical sector, regulatory affairs, government, or a national/international NGO.
• Strong knowledge of pharmaceutical regulatory frameworks, medicine safety, and compliance.
• Familiarity with Good Manufacturing Practices (GMP), pharmacovigilance, dossier evaluation, and medicine licensing requirements.
• Proficiency in ICT applications for regulatory assessment, reporting, and database management.
KEY COMPETENCIES
• Regulatory & Compliance Awareness – Understanding of pharmaceutical regulations, medicine safety, and market authorization.
• Analytical & Problem-Solving Skills – Ability to evaluate complex scientific data, assess risks, and develop solutions.
• Attention to Detail – Ability to review and analyze technical reports, regulatory dossiers, and inspection findings accurately.
• Communication & Stakeholder Engagement – Strong verbal and written communication skills with the ability to engage industry stakeholders, healthcare professionals, and regulators.
• Technical Writing & Report Preparation – Ability to draft clear, structured, and comprehensive reports and regulatory documents.
• Teamwork & Learning Agility – Ability to collaborate effectively while continuously developing regulatory science and compliance knowledge.
• Integrity & Professionalism – High ethical standards, reliability, and ability to handle confidential regulatory matters responsibly.

APPLICATION INSTRUCTIONS
Submit the following to [email protected]:
• Latest CV
• Certified copies of qualifications
• Contact details for two referees
Closing Date: 29 July 2025. Only shortlisted candidates will be contacted.

Introducing the Newly Appointed BoMRA BoardThe Botswana Medicines Regulatory Authority (BoMRA) is pleased to introduce i...
06/07/2026

Introducing the Newly Appointed BoMRA Board

The Botswana Medicines Regulatory Authority (BoMRA) is pleased to introduce its newly appointed Board, whose diverse expertise and strategic leadership will support the Authority in fulfilling its mandate.

OPERATION CLEAN UP THE CITY.Botswana Medicines Regulatory Authority (BoMRA) has confiscated over 5000 unregistered medic...
01/07/2026

OPERATION CLEAN UP THE CITY.

Botswana Medicines Regulatory Authority (BoMRA) has confiscated over 5000 unregistered medical products during a recent joint enforcement operation.

The operation was carried out in collaboration with law enforcement and other regulatory partners targeting businesses and individuals suspected of illegally distributing, marketing, and selling medical products that do not comply with regulatory requirements.

More than 5000 units of unregistered medical products were confiscated during the operation, from various commercial areas and public places within the city, including the city Bus rank and over three (3) shopping malls. A total of 27 cases were registered for further action.

The confiscated products include a wide range of medicines, herbal products, medical devices, and cosmetics that were being sold without the required regulatory approval from BoMRA.

Among the products confiscated were those making therapeutic claims to treat or manage serious chronic conditions such as cancer, diabetes, hypertension, and other medical conditions.

The operation has also exposed a growing trend in the illegal trade of unregistered medical products through informal and unauthorised channels, particularly in busy commercial areas.

Some of these products are also being promoted and sold through social media platforms, where misleading claims are used to attract unsuspecting members of the public and consumers.

Medical products that have not undergone regulatory assessment may expose patients to health risks, including harmful or unknown ingredients, contamination resulting from poor manufacturing or storage conditions, as well as Incorrect dosages or inaccurate product information.

The success of the operation demonstrates the effectiveness of collaborative enforcement. BoMRA is committed to working closely with its enforcement partners to ensure appropriate legal action is taken against individuals and businesses involved in the illegal trade of medical products.

The public is encouraged to exercise caution when purchasing medical products by buying only from licensed pharmacies or authorised retail outlets.

Patients should also verify that medical products are registered with BoMRA and seek advice from qualified healthcare professionals before purchasing or using products that make therapeutic claims.

Report illegal sale, of unregistered medical products, including those advertised through social media to BoMRA directly via the website (www.bomra.co.bw)other platforms

Office Closure Notice – Sir Seretse Khama DayPlease be advised that the Botswana Medicines Regulatory Authority (BoMRA) ...
30/06/2026

Office Closure Notice – Sir Seretse Khama Day

Please be advised that the Botswana Medicines Regulatory Authority (BoMRA) offices will be closed on Wednesday, 1 July 2026, in observance of Sir Seretse Khama Day, a national public holiday.

Normal business operations will resume on Thursday, 2 July 2026.

For urgent regulatory matters requiring immediate attention during the holiday, please contact us via email at:

[email protected]
[email protected]
Import Export: [email protected]

Address

Gaborone

Opening Hours

Monday 08:00 - 17:00
Tuesday 08:00 - 17:00
Wednesday 08:00 - 17:00
Thursday 08:00 - 17:00
Friday 08:00 - 17:00

Telephone

+2673731727

Alerts

Be the first to know and let us send you an email when Botswana Medicines Regulatory Authority posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Botswana Medicines Regulatory Authority:

Share